Best Initial Ascent Podcasts (2025)

1
Javier C Cortés MD PhD: ESMO 2025, Berlin: Initial Therapy with Sacituzumab Govitecan Improves Progression-Free Survival in Patients with Newly-Diagnosed Metastatic Triple Negative Breast Cancer—ASCENT ...

Play Pause

12d ago

—

An interview with: Javier C Cortés MD PhD, Breast Cancer Medical Oncologist, IOB Madrid, Institute of Oncology, Madrid, and International Breast Cancer Centre, Barcelona, Spain BERLIN, Germany—Treatment with the antibody drug conjugate (ADC) sacituzumab govitecan (that targets the Trop-2 cancer-associated protein, delivering a cytotoxic topoisomera…

1
Xiuning Le MD PhD; ESMO 2025: Sevabertinib Success for Patients with HER2-Mutated Non-Small Cell Lung Cancer in SOHO-01 Study

1d ago

—

An interview with: Xiuning Le MD PhD, Medical Oncologist, Department of Thoracic Medicine, UT MD Anderson Cancer Center, Houston TX BERLIN, Germany—Mutations in the HER2 molecule can be found in a few per cent of non-small cell lung cancers, and these can now be targeted by the new drug sevabertinib that can bring benefit to patients who have the m…

1
ESMO 2025; Christof Vulsteke MD PhD: Perioperative Enfortumab Vedotin Therapy With Pembrolizumab Boosts Event-Free and Overall Survival in Platinum-Ineligible Patients with Muscle-Invasive Bladder Cancer ... 0:07

5d ago0:07

0:07

An interview with: Christof Vulsteke MD PhD, Medical Oncologist, Head of the Integrated Cancer Center Ghent, Belgium BERLIN, Germany—Patients with muscle invasive bladder who were ineligible for cisplatin chemotherapy gained large, clinically meaningful and statistically significant benefits from treatment with the antibody drug conjugate enfortuma…

1
Xichun Hu MD PhD; ESMO 2025: Antibody Drug Conjugate Trastuzumab Botidotin Outperforms Trastuzumab Emtansine in Patients with HER2-Positive Unresectable or Metastatic Breast Cancer

6d ago

—

An interview with: Xichun Hu MD PhD, Professor, Director, Department of Medical Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China BERLIN, Germany—In a head-to-head comparison of two antibody drug conjugates used to treat unresectable or metastatic breast cancer, patients treated with trastuzumab botidotin lived more than twice as …

1
When the Shot Doesn’t Hit… What Hunting Teaches You - Chris Young 1:11:43

4d ago1:11:43

1:11:43

Got questions? Send us a text! In this episode of the Mountain Dude Podcast, Chris Young sits down to recap his 2025 early season — chasing antelope across Idaho’s high desert, learning through missed shots, and staying grounded through it all. From spot-and-stalk bowhunting challenges to lessons in faith, family, and perseverance, Chris dives deep…

1
Martin Wermke MD; ESMO 2025: Initial Therapy with Bi-Specific T-cell Engager Tarlatamab Promises Better Outcomes in Patients with Small Cell Lung Cancer

8d ago

—

An interview with: Martin Wermke MD, TU Dresden, NCT/UCC Early Clinical Trial Unit and Medical Clinic, Poliklinik I, Natural Centre for Tumor Diseases, Dresden, Germany BERLIN, Germany—The prospect of markedly better outcomes for patients with small cell lung cancer, with “encouraging initial survival outcomes”, was raised by findings from the DeLL…

1
John P. Crown MD MBA: ESMO 2025, Berlin: Adjuvant Ribociclib Brought Longer Freedom from Metastases for Patients with HR+/HER2- Early Breast Cancer: NATALEE Five Year Outcomes

11d ago

—

An interview with: John P. Crown MD MBA, Consultant Medical Oncologist, St. Vincent’s University Hospital, Dublin, Professor of Translational Cancer Research, Dublin City University, Professor of Medicine, University College Dublin Ireland. BERLIN, Germany—Patients with high-risk node-negative ER-positive HER2-negative early breast cancer who had t…

1
When God Sends You an Elk Tag | Chris Young x Revol Entertainment 1:05:10

12d ago1:05:10

1:05:10

Got questions? Send us a text! In this powerful episode of the Mountain Dude Podcast, we sit down with Chris Young to hear the full story behind his new elk hunting film Late Season Legacy, filmed by Clint Easley of Revol Entertainment and premiering on the Vortex Nation YouTube Channel. What started as a dream tag for a once-in-a-lifetime Idaho el…

1
From Elk Hunts to Angry Dick Leather | The Bettencourt Family Behind Steep Kuntry Outdoors 1:07:38

19d ago1:07:38

1:07:38

Got questions? Send us a text! In this episode of the Mountain Dude Podcast, we sit down with Richard Bettencourt and his dad Dick Bettencourt of Steep Kuntry Outdoors — a father-and-son elk hunting duo who represent what hunting is really about: grit, family, and perseverance. From their first archery bull to building Steep Kuntry into a respected…

1
Trevor Leong MD: Operable Gastric or GE-Junction Adenocarcinoma: No Advantage from Neoadjuvant Radiotherapy

19d ago

—

An interview with: Trevor Leong MD, Peter McCallum Cancer Centre, Radiation Oncology Department, Melbourne, Australia BARCELONA, Spain—Although pre-operative radiotherapy brought better response rates in patients resected for their gastric or GE-junction adenocarcinomas, there was no improvement in survival. This is the clear finding from a big, lo…

1
Thriving in the Mountains Past 60. | Jim Naccarato’s Story 1:04:21

26d ago1:04:21

1:04:21

Got questions? Send us a text! In this episode of The Mountain Dude Podcast, we sit down with Jim Naccarato, founder of Iron Mountain Skull Hangers. From backcountry elk hunts to building some of the most trusted European mount hangers in the industry, Jim shares his story of grit, determination, and craftsmanship. We dive into unforgettable elk hu…

1
Domenica Lorusso MD PhD: Adding Early PD-1 Checkpoint Inhibition brings Big Reduction of Deaths for Patients with Newly Diagnosed Locally Advanced High-Risk Cervix Cancer 7:20

26d ago7:20

7:20

By Audio Medica News

1
James Larkin FRCP, PhD: CheckMate 067 Study 10-Year Data Show Advanced Melanoma Landscape Transformed by Combo Checkpoint Inhibitor Therapy 14:58

29d ago14:58

14:58

An interview with: James Larkin FRCP, PhD, Medical Oncologist, Professor, Royal Marsden Hospital, London Checkpoint inhibitor therapy for advanced melanoma has achieved sustained responses and long-term overall survival, transforming the prognosis for as many as half of all patients. 10-year survival outcomes from the phase Ill CheckMate 067 trial …

1
Jefferson DeKloe BSc: Big US Study Confirms Benefit of HPV Vaccination for Boys as Well as Girls 6:07

1M ago6:07

6:07

An interview with: Jefferson DeKloe BSc, Department of Otolaryngology, Thomas Jefferson University, Philadelphia, PA CHICAGO, USA—Although the take-up of vaccination for human papilloma virus (HPV) among girls and boys in the USA has been lower than in many other industrial countries, American researchers have now shown clearly that in addition to …

1
Rebecca Dent MD: ESMO Previous Highlights: Neo-Adjuvant Therapy for Triple Negative Breast Cancer, Checkpoint Inhibition, AI, Cancer Vaccines, and More …… 13:13

1M ago13:13

13:13

An interview with Rebecca Dent MD, Deputy Chief Executive Officer, National Cancer Centre, Singapore, ESMO 2024 Scientific Chair. ESMO Previous Highlights: Neo-Adjuvant Therapy for Triple Negative Breast Cancer, Checkpoint Inhibition, AI, Cancer Vaccines, and More ……” BARCELONA, Spain—At the last Annual Meeting of the European Society for Medical O…

1
Behind the Lens with Clint Easley (Filmmaking, Storytelling & Real Backcountry Grit) 1:21:03

1M ago1:21:03

1:21:03

Got questions? Send us a text! In this episode, we sit down with Clint Easley, filmmaker, hunter, and founder of Revol Entertainment, to uncover what really goes into crafting powerful hunting films in the backcountry. From wedding shoots to wild terrain, Clint shares the highs, lows, and behind-the-scenes chaos of filming in unforgiving environmen…

1
Bart Neyns MD PhD: Patients with Recurrent Glioblastoma Lived Markedly Longer in Phase 1 Study of Intracranial Autologous Myeloid Dendritic Cell Therapy 10:55

1M ago10:55

10:55

Audio Journal of Oncology interview with: Bart Neyns MD PhD, Vrije Universiteit Brussel, Faculty of Medicine and Pharmacy, Medical Oncology Department, Brussels, Belgium BARCELONA, Spain—Intracranial administration of autologous dendritic cells was combined with combination checkpoint inhibition in a phase 1 study of patients with recurrent gliobla…

1
Victor Velculescu MD PhD: Ovarian Cancer Noninvasive Detection by Circulating DNA Fragmentome and Protein Biomarker AI Analysis 13:33

1M ago13:33

13:33

An interview with: Victor Velculescu MD PhD, Co-director, Cancer Genetics & Epigenetics Program, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. SAN DIEGO, USA—A blood test using an artificial intelligence DNA pattern recognition system that brings earlier, more certain detection of o…

1
Become a Better Shooter: Rodger Holscher 1:17:34

1M ago1:17:34

1:17:34

Got questions? Send us a text! Last week's episode's audio was the story part, btw. We apologize. In this episode of the Mountain Dude Podcast, we sit down with Rodger Holscher—law enforcement officer, lifelong hunter, and one of the most dialed riflemen you'll ever meet. From growing up on a California cattle ranch to navigating high-stakes situat…

1
Timothy Yap MD PhD MBBS: Selective PARP1 Inhibitor Saruparib Clinical Promise in Solid Tumors with Homologous Recombination Repair Deficiency 18:45

1M ago18:45

18:45

Audio Journal of Oncology: Sept 23rd, 2025 An interview with: Timothy Yap MD PhD MBBS, Professor of Investigational Cancer Therapeutics, Head of Clinical Development, Therapeutics Discovery Division, University of Texas MD Anderson Cancer Center, Houston, USA SAN DIEGO, USA—Breast, ovarian, pancreatic, prostate and other solid tumors with mutations…

1
Stacey Kenfield ScD and June Chan ScD: Prostate Cancer Management: New Evidence of Big Benefit from Exercise: 10:28

2M ago10:28

10:28

Interviews with: Stacey A. Kenfield ScD, Epidemiologist, Professor of Urology, Epidemiology and Biostatistics, and June Chan ScD, Cancer Epidemiologist, Department of Epibiostat and Urology, University of California San Francisco, California USA. SAN DIEGO, USA—Physical exercise keeps patients with prostate cancer alive longer, according to a combi…

1
Jonathan T. Yang MD PhD: Radiosensitizer Shows Early Clinical Promise to Support Glioblastoma Radiotherapy 10:59

2M ago10:59

10:59

An interview with Jonathan T. Yang MD PhD, Washington University, Seattle, USA, (Formerly of Memorial Sloan Kettering Cancer Center, New York.) SAN DIEGO, USA—An international phase one clinical study has found that a drug known to inhibit DNA damage repair was able to boost the efficacy of radiotherapy in patients being treated for their glioblast…

1
Heather McArthur MD MPH: Adjuvant Checkpoint Inhibition: Did Not Improve Survival in Patients with Triple-Negative Breast Cancer 10:06

2M ago10:06

10:06

An interview with: Heather McArthur MD MPH, Clinical Director Breast Cancer, Komen Distinguished Chair Clinical Breast Research, University of Texas Southwestern Medical Center, Dallas TX MILAN, Italy—Adjuvant therapy with a checkpoint inhibitor did not benefit patients with triple negative breast cancer in a big new study reported to the 14th Euro…

1
Stefan Paepke MD: An End to “Jumping Breasts” with Mesh Supported Pre-Pectoral Breast Implants 10:48

2M ago10:48

10:48

An interview with: Stefan Paepke MD, Interdisciplinary Breast Centre, Technical University of Munich, Germany, recorded at the 14th European Breast Cancer Conference, Milan, Italy. MILAN, Italy—Women who need surgical implants after their mastectomy for breast cancer could now benefit from mesh-supported prosthetics that bring high rates of satisfa…

1
Elk at 12 Yards, Bears in the Dark & No Spoon for 3 Days with Rodger Holscher 1:13:27

2M ago1:13:27

1:13:27

Got questions? Send us a text! Rodger Holscher is back in the studio—and this time, it’s not just tactics and gear talk. This is full-on story mode. From nearly bonking out after three days without a spoon to punching his tag on a bull at 12 yards, Rodger walks us through some of his most unforgettable backcountry hunts with Chris and the crew. Whe…

1
Sophie Bosma MD PhD:“Young Boost” Trial Finds Low-Dose Radiation Boost Optimal for Young Patients with High-Risk Early Breast Cancer 8:46

2M ago8:46

8:46

An interview with Sophie Bosma MD PhD, from The Netherlands Cancer Institute, Amsterdam recorded at the 14th European Breast Cancer Conference in Milan. MILAN, Italy—The optimal radiation boost dose to protect young patients with early breast cancer has been investigated with ten years of follow up in the “Young Boost trial” conducted in the Nether…

1
Adri Voogd PhD: Ductal Carcinoma in Situ: Good Outcomes from Breast Conserving Therapy, but Benefits, Risks, Costs Still Need to be Optimized 15:54

2M ago15:54

15:54

An interview with: Adri Voogd PhD, Associate Professor of Clinical Epidemiology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands MILAN, Italy—Although outcomes following breast conserving surgery (with or without radiotherapy) for ductal carcinoma in situ (DCIS) are excellent, it is still not clear …

1
Annemiek van Hemert MD PhD: “Breast Cancer: MARI Node Marker Helps Most Patients with Extensive Nodal Disease Safely Avoid Axillary Lymph Node Dissection” 10:16

2M ago10:16

10:16

An interview with Annemiek van Hemert MD PhD, Surgical Oncology Department, Antoni van Leeuwenhoek-Netherlands Cancer Institute (AVL-NKI), Amsterdam Netherlands MILAN, Italy—Four out of five patients with extensive nodal spread of their breast cancer could be spared extensive axillary dissection, if a new method of marking lymph nodes is used. That…

1
Tim Rattay MBChB PhD: Artificial Intelligence Tool Minimizes Arm Lymphedema After Breast Cancer Surgery and Radiotherapy 14:05

2M ago14:05

14:05

An interview with: Tim Rattay MBChB PhD, Consultant Breast Surgeon, University Hospitals of Leicester, Associate Professor in Breast Surgery, Leicester Cancer Research Centre, University of Leicester, England, UK. A report from the 14th European Breast Cancer Conference, Milan, Italy MILAN, Italy—An artificial intelligence tool can predict the risk…

1
Why Most Hunters Quit Early (And How to Push Through): Chris Young 43:56

2M ago43:56

43:56

Got questions? Send us a text! Welcome back to the Mountain Dude Podcast by Initial Ascent. In this solo episode, host Chris Young dives deep into the one factor that separates successful hunters from those who come home empty-handed: mental toughness. From chasing bugles deep in September elk country to grinding through long solo hunts, Chris shar…

1
Yasmin Civil MD PhD: Low-Risk ER+ Breast Cancer: ABLATIVE Trial Finds Marked Benefit from MRI-Guided Single-Dose Neoadjuvant Partial Breast Radiotherapy 9:13

2M ago9:13

9:13

An interview with Yasmin Civil MD PhD, UMC Hospital, Amsterdam, Netherlands. MILAN, Italy—Offering MRI-guided partial breast irradiation before surgery to patients with low-risk breast cancer could become the norm, according to Yasmin Civil MD PhD from the UMC Hospital in Amsterdam, who reported five-year results from the ABLATIVE trial of pre-oper…

1
Neo-Adjuvant Pembrolizumab Improved Outcomes with High-Risk ER+ HER2- Early Breast Cancer 8:55

2M ago8:55

8:55

An interview with Heather McArthur MD MPH, Clinical Director of Breast Cancer, Komen Distinguished Chair in Clinical Breast Research, University of Texas Southwestern Medical Center, Dallas, USA MILAN, Italy—Patients with early breast cancer testing positive for estrogen receptor (ER+) and negative for human epidermal growth factor receptor 2 (HER2…

1
Training, Faith & 40+ Packouts a Year: "Hollywood" Dave Beronio 1:04:28

2M ago1:04:28

1:04:28

Got questions? Send us a text! In this episode, we sit down with “Hollywood” Dave Beronio, elite athlete, guide, packout machine, and wedding officiant with over 1,500 ceremonies under his belt. From the ski slopes of Lake Tahoe to hauling 50 animals a year off Utah’s peaks, Dave’s story is one of relentless drive and intentional living. He opens u…

1
Laura J. van ’t Veer PhD: Triple Negative Early Breast Cancer Genetic Sub-Types Predict No Benefit from Neoadjuvant Pembrolizumab 15:48

2M ago15:48

15:48

An interview with: Laura J. van ’t Veer PhD, Professor of Laboratory Medicine, Co-leader of the Breast Oncology Program, Director of Applied Genomics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. MILAN, Italy—Around 25 per cent of patients with newly-diagnosed triple negative breast cancer will not benef…

1
The E-scouting Guru and the Secrets to Elk Hunting Success: Mark Livesay 1:18:32

2M ago1:18:32

1:18:32

Got questions? Send us a text! On this episode of the Mountain Dude Podcast, we’re joined by none other than Mark Livesay—the E-Scouting Master behind TreeLine Academy and one of the most respected educators in the elk hunting world. Mark has spent decades refining his system for digital scouting elk hunting areas and has taught thousands of hunter…

1
Érica A. Oliveira PhD: How to Overcome Drug Resistance: Patient Derived Organoids Study Finds Epigenetic Pathways in Colorectal Cancer 24:30

2M ago24:30

24:30

Érica A. Oliveira PhD: How to Overcome Drug Resistance: Patient Derived Organoids Study Finds Epigenetic Pathways in Colorectal Cancer Interviews with: Érica A. Oliveira PhD, Senior Scientific Officer, Genomics and Evolutionary Dynamics, Institute of Cancer Research, Sutton, London UK And: Christopher Sng MD, Clinical Research Fellow, Institute of …

1
Elk Calling Tactics, Hunting Lessons, and Real-life Challenges: Cody McCarthy 1:17:04

2M ago1:17:04

1:17:04

Got questions? Send us a text! In this episode of The Mountain Dude Podcast, we sit down with Cody McCarthy—elk caller, Slayer Calls pro, and man of faith—to hear his incredible journey from killing his first bull at 12 years old to becoming one of the most respected voices in the elk hunting world. Cody shares raw, emotional stories from his early…

1
The Legend of The Bugler: Dirk Durham 1:32:25

3M ago1:32:25

1:32:25

Got questions? Send us a text! In this episode of the Mountain Dude Podcast, we're joined by none other than Dirk Durham, aka The Bugler, a backcountry legend and one of the most respected elk callers in the game. From his stormy-night birth in rural Idaho to bowhunting elk for over three decades, Dirk walks us through the experiences that shaped h…

1
Christian Singer MD: Neoadjuvant Olaparib Combination Beats Standard of Care in Patients with Homologous Recombination Deficient BRCA 1/2-Positive Triple-Negative Breast Cancer 10:32

3M ago10:32

10:32

Audio Journal of Oncology, August 5th, 2025 An interview with: Christian Singer MD, Head, Center for Breast Health, Department of Obstetrics & Gynecology, Comprehensive Cancer Center, Medical University of Vienna. CHICAGO, USA—Your patients whose triple-negative breast cancers test positive for BRCA 1/2 mutations, could do better if you gave them t…

1
Elk Every Year: Zach Bowhay’s Secrets to Long-Term Success in the West 1:00:41

3M ago1:00:41

1:00:41

Got questions? Send us a text! Zach Bowhay is one of the most consistently successful elk hunters in the West. In this episode, he joins the Mountain Dude Podcast to break down what it really takes to fill tags year after year—without relying on hype, gimmicks, or lucky draws. From generational hunting knowledge to mental toughness, Zach shares the…

1
Rebecca Dent MD: First-Line T-DXd Combination Adds More Than a Year of Progression Free Survival for Patients with Advanced HER2 Positive Breast Cancer 16:49

3M ago16:49

16:49

With: Sara M Tolaney MD MPH, Chief, Division of Breast Oncology, Dana-Farber Cancer Institute, Associate Professor of Medicine, Harvard Medical School, Boston USA And interviews with: Rebecca Dent MD, Deputy Chief Executive Officer, National Cancer Center, Singapore And: Giuseppe Curigliano MD PhD, Director, Early Drug Development for Innovative Th…

1
Burning Beds, Backcountry Demons & Bowhunting Elk with Nate Illingsworth 1:04:49

3M ago1:04:49

1:04:49

Got questions? Send us a text! In this raw and hilarious episode, Nate Illingsworth joins the Mountain Dude Podcast to share his insane journey—from nearly burning down his house mid-romance to losing 80 pounds and tackling backcountry elk hunts head-on. Nate opens up about fitness, faith, mental resilience, and the power of doing hard things—all w…

1
Gear Talk Pt 2: Clothing Systems & the Merino vs Synthetic Debate 1:15:40

3M ago1:15:40

1:15:40

Got questions? Send us a text! In this episode of Gear Talk, we go deep into clothing systems for backcountry hunting. From the hot debate of Merino wool vs synthetic base layers to how to layer effectively without overpacking, this is your ultimate breakdown of what to wear, when, and why. Whether you’re prepping for spring bear or late-season elk…

1
Erica L. Mayer MD MPH: Adjuvant Abemaciclib: Start Low, then Dose Escalate in Early-stage HR+/HER2- Breast Cancer: TRADE Study Findings 9:29

4M ago9:29

9:29

Interview with Erica L. Mayer MD MPH, Director of Breast Cancer Clinical Research, Breast Oncology Program, Dana-Farber Cancer Institute, Boston, USA. With comment from: Pat Price MD, Imperial College London, UK, Chair, Global Coalition for Radiotherapy. CHICAGO, USA—Avoiding therapy discontinuation was the focus of the TRADE study looking at abema…

1
Gear Talk Pt 1: Basecamp vs Backpack Hunting | Backcountry Nutrition, Gear Tips 1:13:33

4M ago1:13:33

1:13:33

Got questions? Send us a text! In this episode, we dive deep into the backcountry, from the comfort of basecamp hunts to the grind of true backpack-style missions. We swap personal hunting stories, break down gear essentials like backcountry chairs, and talk about how to balance comfort and pack weight when you're miles deep. We also hit on one of …

1
Patients with Early-Stage Non-Squamous Non-Small Cell Lung Cancer Who can Benefit from Adjuvant Chemotherapy 11:41

4M ago11:41

11:41

An interview with: David R Spigel FASCO, MD, Chief Scientific Officer, Sarah Cannon Research Institute, Nashville, Tennessee, US With comment from: Luis G Paz-Ares MD PhD Chair of Medical Oncology, Hospital Universitario 12 de Octubre, Universitario de Madrid CHICAGO, USA—Although patients with early non-squamous non-small cell lung cancer can be c…

1
The Hollywood Cameraman: Clint Easley 1:04:32

4M ago1:04:32

1:04:32

Got questions? Send us a text! In this episode, we sit down with Clint Easley, a former architect to the stars turned full-time filmmaker and mountain hunter. From designing homes for Hollywood elites to filming in the remote wilds of Alaska, Clint’s story is one of bold transitions, relentless creativity, and a calling to something deeper. This co…

1
Adjuvant Nivolumab Extends Disease-Free Survival in Patients with High-Risk Head and Neck Cancers 10:00

4M ago10:00

10:00

An interview with Jean Bourhis MD PhD, Head of Service of radiation oncology, Lausanne University Hospital, Lausanne, Switzerland. And with: Pat Price MD, Imperial College London, UK, Chair, Global Coalition for Radiotherapy. SARAH MAXWELL Disease free survival was extended in patients with head and neck cancers who had Nivolumab added to their sta…

1
Dan Whitmus Stabbed Himself in Alaska and SURVIVED! 1:01:46

4M ago1:01:46

1:01:46

Got questions? Send us a text! In this episode, we sit down with legendary hunting guide Dan Whitmus, a man who’s lived over 30 years in the wilderness guiding hunters through Alaska, Africa, New Zealand, and the American West. Dan shares jaw-dropping stories, including surviving a self-inflicted knife wound deep in the bush, 300+ pound solo packou…

1
Luis Paz-Ares MD PhD: Longer Survival Among Patients with Extensive Stage Small Cell Lung Cancer Treated with Lurbinectedin Maintenance —ASCO 2025 11:51

4M ago11:51

11:51

Audio Journal of Oncology An interview with: Luis G Paz-Ares MD PhD, Chair of Medical Oncology, Hospital Universitario 12 de Octubre, Universitario de Madrid Comment by: Julie R. Gralow MD FACP FASCO, Chief Medical Officer and Executive Vice President, American Society of Clinical Oncology. https://www.audiomedica.com/wp-content/2025/06/Luis-Paz-Ar…